Evidence map›Paper›PMID 35169000›Full record

ArticleJournal of investigative medicine : the official publication of the American Federation for Clinical Research2022

Metabolic derangement in patients with vitiligo: a cross-sectional study.

Zeinab Aryanian, Azar Shirzadian, Sepideh Farzaneh, Azadeh Goodarzi, Arghavan Azizpour, Parvaneh Hatami

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05549869 (Assessment of Serum Leptin in Vitiligo Patients), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05549869 naunknown statusnot on this map

Assessment of Serum Leptin in Vitiligo Patients

TypeinterventionalSponsorSohag UniversityRan2022 to 2023Enrolled400ConditionsVitiligoArmsserum leptin
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zeinab AryanianAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Azar ShirzadianDepartment of Dermatology, Babol University of Medical Sciences, Babol, Mazandaran, Iran.
Sepideh FarzanehDepartment of Dermatology, Babol University of Medical Sciences, Babol, Mazandaran, Iran.
Azadeh GoodarziDepartment of Dermatology, Iran University of Medical Sciences, Tehran, Iran.
Arghavan AzizpourAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Parvaneh HatamiAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran p_hatami2001@yahoo.com.ORCID 0000-0002-3531-2907
Tehran University of Medical Sciences · IRBabol University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitiligo is a pigmentary disorder resulting from progressive destruction of melanocytes in the skin. There is a growing body of evidence about higher risk of metabolic syndrome and dyslipidemia in some dermatoses including vitiligo. We aimed to evaluate lipid profile, leptin and C reactive protein (CRP) status among Iranian patients with vitiligo, compared with healthy controls and perused the relationship between abnormal values of these parameters with disease duration and physical characteristics of patients. 40 patients with vitiligo and 40 age-matched and sex-matched healthy controls were enrolled in the study. Data on weight, height, lipid profile, leptin and CRP values were recorded and compared. The mean values for nearly all study parameters (except for high-density lipoprotein) were significantly higher in patients with vitiligo, compared with healthy controls, irrespective of age and sex. We could not find any correlation between vitiligo and study parameters, regarding disease severity and extension of lesions; but in patients who have been suffering from vitiligo for more than 5 years, systolic blood pressure, diastolic blood pressure and CRP values were noted to be significantly higher (p<0.001, p=0.003 and p=0.03, respectively). In conclusion, screening of patients with vitiligo in regard to their lipid profile as well as blood pressure should be considered, especially in patients with longer disease duration or those who have other cardiovascular risk factors to prevent morbidity and mortality as a result of developing cardiovascular events.

Indexed as

LeptinVitiligoCross-Sectional StudiesHumansIranLipidsLeptinLipidscardiovascular diseasesdyslipidemiasinflammationlipid metabolism

Identifiers

PMID35169000
PMCPMC9016231
OpenAlexW4213140411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.